Form 4 holding
Director
CATALYST BIOSCIENCES, INC.
- Security class
- Common Stock
- Shares / value
- 31,790
- Estimated value
- $14,941
- Report date
- 07 Jan 2022
- Price
- $0.4700
- Ownership
- Direct
Geoffrey Ling MD - Director at GYRE THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- GYRE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Geoffrey Ling MD since 05 Sep 2025
Reported holdings for Geoffrey Ling MD in GYRE THERAPEUTICS, INC.
Transaction history for Geoffrey Ling MD in GYRE THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.